Orally-administered interferon-tau compositions and methods

Details Orally-administered interferon-tau compositions and methods Orally-administered interferon-tau compositions and methods

2007-05-08

2007-05-08

Campell, Bruce R. (Department: 1648)

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

C930S142000, C530S351000, C536S023520

Reexamination Certificate

active

10694247

ABSTRACT:
The present invention includes interferon-tau (IFNτ) pharmaceutical compositions useful for oral administration to treat cancers, autoimmune disorders (particularly multiple sclerosis), cell proliferative disorders and viral disease.

REFERENCES:
patent: 4997646 (1991-03-01), Hansen et al.
patent: 5019382 (1991-05-01), Cummins, Jr.
patent: 5206219 (1993-04-01), Desai
patent: 5372808 (1994-12-01), Blatt et al.
patent: 5705363 (1998-01-01), Imakawa
patent: 5906816 (1999-05-01), Soos et al.
patent: 6372206 (2002-04-01), Soos et al.
patent: WO 90/09806 (1990-09-01), None
patent: WO 94/10313 (1994-05-01), None
patent: WO 95/27499 (1995-10-01), None
patent: WO 95/27502 (1995-10-01), None
Amidon, G.L., et al.,Peptide and Protein Drug Delivery 43:146-152 (1998).
Anonymous,Lancet 336(8720):935 (1990).
Aranason, et al.,Clinical Neuropharmacology 17(16):495-547, (1994).
Banga, A.K., “Oral Delivery of Peptide and Protein Drugs,” (Chapter 8) inTherapeutic Petides and Proteins: Formulation, Processing, and Delivery Systems, Technomic Publishing Co., Inc., Lancaster, PA, pp. 217-243 (1995).
Brod, S.A., and Burns, D.K.,Neurology 44:1144-1148 (1994).
Brod, S.A., et al.,J. Interferon Res. 15:115-122 (1995).
Brod, S., et al.,J of Interferon and Cytokine Research 15(2):115-122 (1995).
Brod, S. and Khan, M.,J of Autoimmunity 9(1):11-20 (1996).
Caban, J., et al.,Archivum Immunologiae et Therapiae Experimentalis 41(3-4):229-235 (1993).
Cummins, J.M., et al.,Veterinary Immunology and Immunopathology 45(3-4):355-60 (1995).
Cummins, J.M.,J. Biol. Response Modif 7(5):513-523 (1988).
Degre, M. and Bukholm, G.,J of Biological Regulators and Homeostatic Agents 9(1):15-20 (1995).
Dermer, G.B.,Bio/Technology 12:320, (1994).
Fleischmann, W., et al.,Proceedings of the Society for Experimental Biology and Medicine 201(2):200-7 (1992).
Freshney, R.I.,Culture of Animal Cells: A Manual of Basic Technique, Alan R. Liss, Inc., NY, NY, pp. 3-4, (1983).
Georgiades, J.A.,Archivum Immunologiae et Therapiae Experimentalis 44(1):11-22 (1996).
Georgiades, J.A.,Archivum Immunologiae et Therapiae Experimentalis 41(3-4):259-265 (1993).
Hutchinson, V.A., et al.,Mol Biother 2(3):160-164 (1990).
Imakawa, K., et al.,Nature, 330:377-379, (1987).
Johnson, H.M., et al.,Scientific American 270(5):40-47 (1994).
Koren, S., et al.,Proceedings of the Society for Experimental Biology and Medicine 204(2):155-164 (1993).
Lecce, J.G., et al.,Mol Biother 2(4):211-216 (1990).
Moore, B., et al.,Veterinary Immunology and Immunopathology 49(4):347-358 (1996).
Nelson, P.A., et al.,Annals of the New York Academy of Sciences, 778:145-155 (1996).
Pontzer, C.H., et al., Biochem. Biophys. Res. Commun., 152(2):801-807, (1988).
Pontzer, C.H., et al.,Cancer Research 51:5304-5307 (1991).
Qi, Y., et al.,Hum Antibod Hybridomas 7(1):21-26 (1996).
Ranade, V.V. and Hollinger, M.A.,Drug Delivery Systems, CRC Press Inc. Boca Raton, Florida pp. 127-128, 151 (1996).
Shiozawa, K., et al.,Arthritis&Rheumatism 39(9):S63 (1996).
Soos, J.M., and Johnson, H.M.,J. Interferon Res. 15:39-45 (1995).
Soos, J.M., et al.,J. Immunol. 155:2747-2753 (1995).
Soos, J.M., et al.,FASEB J. Experimental Biol. 9(4):Abs. No. 5940 (1995).
Weiss, R.C., et al.,J. Am. Vet. Med. Assoc. 199(10):1477-1481 (1991).
Wills, R.J., et al.,Journal of Interferon Research 4(3):399-409 (1984).
Witt, P., et al.,J of Interferon Research 12(6):411-413 (1992).
Zielinska, W., et al.,Archivum Immunologiae et Therapiae Experimentalis 41(3-4):241-251 (1993).

Affiliated with

Also associated with

Rating

Orally-administered interferon-tau compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Orally-administered interferon-tau compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally-administered interferon-tau compositions and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3721221